New treatments are being developed by the biopharmaceutical industry in collaboration with the government and FDA to help treat COVID-19 and new variants. In this week’s episode, we break down these new treatments and therapies, and discuss what they mean for patients.
"It is important for us to have multiple therapies-even within those classes-to make sure that patients have choice and that physicians, pharmacists, and nurses have choices that can then appropriately treat the patient," says Dr. Robert Popovian, Chief Science Policy Officer at the Global Healthy Living Foundation.
Among the highlights in this episode:
1:32: Listener review
2:07: A look at the treatments and therapies that are being developed for COVID-19
3:38: What therapies are currently available?
4:34: Will these treatments stay effective as the virus changes into different variants?
5:46: What are some of the concerns about these treatments?
6:41: "Science evolves, and it's important to evolve our treatment choices as science evolves," says Robert.
7:16: Were these treatments developed specifically for COVID-19?
9:31: What have we learned from the COVID-19 vaccines to make the treatments more accessible?
11:13: Since COVID-19 is a virus that is likely here to stay, how important are treatments for the long-run?
12:08: Robert shares his final thoughts
Contact our hosts:
Dr. Robert Popovian, Chief Science Policy Officer at GHLF: firstname.lastname@example.org
Conner Mertens, Patient Advocate and Community Outreach Manager at GHLF: email@example.com
We want to hear what you think. Send your comments, or a video or audio clip of yourself to Healthcarematters@GHLF.org.
Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.
See omnystudio.com/listener for privacy information.